Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
JINS Holdings's 10-Year RORE % for the quarter that ended in Feb. 2026 was 18.15%.
The industry rank for JINS Holdings's 10-Year RORE % or its related term are showing as below:
JNDOF's 10-Year RORE % is ranked better than 83.88% of 428
companies
in the Medical Devices & Instruments industry
Industry Median: 0.735
vs JNDOF: 18.15
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
JINS Holdings 10-Year RORE % Related Terms
JINS Holdings 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for JINS Holdings's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JNDOF vs ISRG, BDX, MDLN: 10-Year RORE % Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings 10-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where JINS Holdings's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Feb. 2026 and 10-year before.
JINS Holdings (JNDOF) has a 10-Year RORE % of 18.15 as of Feb. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on JINS Holdings and its competitors. According to the industry distribution chart, JINS Holdings ranks #69 out of 428 companies in the Medical Devices & Instruments industry, placing it in the top 16.1%.
Is JINS Holdings' 10-Year RORE % too high?
JINS Holdings' current 10-Year RORE % is 18.15. The Medical Devices & Instruments industry median 10-Year RORE % is 0.74. JINS Holdings' value of 18.15 is 2369.4% above this industry median. Based on the distribution chart, JINS Holdings ranks #69 out of 428 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' 10-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #69 out of 428 companies for 10-Year RORE %. This places JINS Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 0.74. JINS Holdings' value of 18.15 is 2369.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Devices & Instruments company?
The median 10-Year RORE % among Medical Devices & Instruments companies is 0.74, based on 428 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current 10-Year RORE % of 18.15 is 2369.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median 10-Year RORE % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current 10-Year RORE % is 18.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (JNDOF) has a current 10-Year RORE % of 18.15. The stock's GF Value™ is $42.68, compared to a current price of $38.43 — trading 10% below its estimated fair value. The current 10-Year RORE % is 18.15 and 2369.4% above the Medical Devices & Instruments industry median of 0.74. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current 10-Year RORE % is 18.15 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 10% below its estimated GF Value™ of $42.68.
Key valuation signals for JNDOF:
10-Year RORE %: 18.15
GF Value™: $42.68 vs. price of $38.43 (10% below fair value)
Industry Position: 2369.4% above the Medical Devices & Instruments median (#69 of 428)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for JNDOF
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
